ARDS Patients Improve with Experimental Treatment
A proof-of-concept study suggests a monoclonal antibody could offer much-needed treatment for ARDS.
A proof-of-concept study suggests a monoclonal antibody could offer much-needed treatment for ARDS.
The inaugural Progressive Pulmonary Fibrosis Symposium brought leading lung disease researchers and clinicians to the institute.
Joe G.N. “Skip” Garcia, M.D., a member of the National Academy of Medicine, has been named associate VP for research at UF Health. He will be based at UF Scripps in Jupiter, Florida.